Sun Pharmaceutical Industries Ltd. closed 14.51% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

Sensex Shake-Up | ITC Profit Soars | Sun Pharma Slides | No More 'Lodha' Wars | Top 5 News | Top 5 Podcast News | Top of The Morning | Mint Podcast | Latest Podcast | Sensex News | Sensex Updates | ...

Sun Pharmaceutical Industries Ltd. closed 14.13% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

The Competition Commission of India (CCI) has introduced new regulations in 2025 for determining production costs, enhancing its ability to tackle predatory pricing and deep discounting ...

A larger share of profits also comes from India and other markets, which helps cushion potential hits from the US side. In contrast to the US market, Sun’s domestic pharma business has been ...

From the labs of India’s top drug-makers to popular health supplement manufacturers, the entry of weight loss and anti-diabetic drug Mounjaro in the Indian market has sparked fierce competition ... s ...

Sun Pharma was founded in 1983 and is one of the world’s biggest manufacturers of generic pharmaceuticals, which are also a major export product for India. The company has diversified into a ...

HYDERABAD/BENGALURU (Reuters) -Sun Pharmaceutical ... Most of India’s generic drugmakers derive a significant share of revenue from the United States, where lower drug prices due to stiff competition ...

Summary: The Supreme Court’s judgment in Coal India Ltd vs Competition Commission of India (2023 ... [9] Employees Provident Fund Commissioner v Official Liquidator of Esskay Pharmaceuticals Limited ...

Sun Pharmaceutical Industries Ltd, India’s largest drugmaker ... it will have to wait till the patent expires in December 2026, and competition from other generic players could intensify.

Oct 28 (Reuters) - Sun Pharmaceuticals (SUN.NS), opens new tab, India's largest drugmaker by ... lower pricing amid stiff competition and increased inspections of generic drug manufacturing ...